首页 > 最新文献

Oman Journal of Ophthalmology最新文献

英文 中文
Peripapillary nerve fiber layer in patients with iron-deficiency anemia: A cross-sectional study at a tertiary eye care center in Central India. 缺铁性贫血患者的毛周神经纤维层:印度中部一家三级眼科医疗中心的横断面研究。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_229_23
Rajesh Subhash Joshi, Rajesh Namdeo Ingle
{"title":"Peripapillary nerve fiber layer in patients with iron-deficiency anemia: A cross-sectional study at a tertiary eye care center in Central India.","authors":"Rajesh Subhash Joshi, Rajesh Namdeo Ingle","doi":"10.4103/ojo.ojo_229_23","DOIUrl":"10.4103/ojo.ojo_229_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"306-307"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic dacryocystitis: An insight into bacteriology and antimicrobial sensitivity pattern. 慢性泪囊炎:细菌学和抗菌药敏感性模式透视。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_116_23
Vibhuti Sethi, Himanshu Kumar Mittal, Rajeev Tuli

Context: Adequate management of chronic dacryocystitis is an essential prerequisite before any intraocular surgery owing to a grave risk of endophthalmitis. The knowledge of bacteriology of chronic dacryocystitis would accentuate the choice of effective antimicrobial agents and thus help in reducing the irrational use of antimicrobial agents and subsequent development of drug resistance.

Aims: We aimed to identify the causative bacterial flora and study the antimicrobial sensitivity and resistance pattern in cases of chronic dacryocystitis.

Settings and design: This was a cross-sectional observational study.

Subjects and methods: Conjunctival swabs were obtained from both eyes from 102 patients with clinical evidence of chronic dacryocystitis. Specimens for microbiological analysis were obtained, either from the conjunctival cul-de-sac and everted puncta by applying pressure over the lacrimal sac area or from the refluxing material after irrigating the lacrimal sac with sterile saline. The specimens were sent for culture and sensitivity in the department of microbiology. Ethical approvals were duly obtained.

Statistical analysis used: Percentage assessment was used for statistical analysis.

Results: The cultures showed the presence of Staphylococcus aureus in 50% of bacterial isolates obtained from the involved eyes, followed by coagulase-negative Staphylococcus in 11.53% of isolates and Enterococcus also in 11.53% of isolates. It was observed that cefoxitin was the most sensitive antibiotic against Gram-positive organisms, followed by vancomycin and clindamycin, whereas maximum resistance was seen for penicillin and ofloxacin. For Gram-negative organisms, imipenem was found to be most sensitive, followed by gentamicin and co-amoxiclav, whereas maximum resistance was seen for ciprofloxacin.

Conclusions: It was concluded that Gram-positive bacteria predominantly S. aureus was the most commonly isolated bacteria in cases of chronic dacryocystitis as compared to Gram-negative bacteria and cefoxitin was found to be the overall most effective antibiotic for Gram-positive bacteria.

背景:由于眼内炎的风险很高,因此在进行任何眼内手术之前,对慢性泪囊炎进行适当处理是必不可少的先决条件。对慢性泪囊炎细菌学的了解将有助于选择有效的抗菌药物,从而减少抗菌药物的不合理使用和耐药性的产生。目的:我们旨在确定慢性泪囊炎病例中的致病菌群,并研究其对抗菌药物的敏感性和耐药性模式:这是一项横断面观察性研究:从 102 名有慢性泪囊炎临床证据的患者的双眼中采集结膜拭子。用于微生物分析的标本是通过在泪囊区域加压从结膜窦和外翻的穿刺点获取的,或者是在用无菌生理盐水冲洗泪囊后从反流物中获取的。标本送至微生物学部门进行培养和药敏试验。已正式获得伦理批准:统计分析采用百分比评估:结果:培养结果显示,从患眼分离出的细菌中,50%为金黄色葡萄球菌,11.53%为凝固酶阴性葡萄球菌,11.53%为肠球菌。据观察,头孢西丁是对革兰氏阳性菌最敏感的抗生素,其次是万古霉素和林可霉素,而青霉素和氧氟沙星的耐药性最高。对于革兰氏阴性菌,亚胺培南最敏感,其次是庆大霉素和联合阿莫西林,而耐药性最强的是环丙沙星:结论:与革兰氏阴性菌相比,以金葡菌为主的革兰氏阳性菌是慢性泪囊炎病例中最常分离到的细菌,而头孢西丁是对革兰氏阳性菌最有效的抗生素。
{"title":"Chronic dacryocystitis: An insight into bacteriology and antimicrobial sensitivity pattern.","authors":"Vibhuti Sethi, Himanshu Kumar Mittal, Rajeev Tuli","doi":"10.4103/ojo.ojo_116_23","DOIUrl":"10.4103/ojo.ojo_116_23","url":null,"abstract":"<p><strong>Context: </strong>Adequate management of chronic dacryocystitis is an essential prerequisite before any intraocular surgery owing to a grave risk of endophthalmitis. The knowledge of bacteriology of chronic dacryocystitis would accentuate the choice of effective antimicrobial agents and thus help in reducing the irrational use of antimicrobial agents and subsequent development of drug resistance.</p><p><strong>Aims: </strong>We aimed to identify the causative bacterial flora and study the antimicrobial sensitivity and resistance pattern in cases of chronic dacryocystitis.</p><p><strong>Settings and design: </strong>This was a cross-sectional observational study.</p><p><strong>Subjects and methods: </strong>Conjunctival swabs were obtained from both eyes from 102 patients with clinical evidence of chronic dacryocystitis. Specimens for microbiological analysis were obtained, either from the conjunctival cul-de-sac and everted puncta by applying pressure over the lacrimal sac area or from the refluxing material after irrigating the lacrimal sac with sterile saline. The specimens were sent for culture and sensitivity in the department of microbiology. Ethical approvals were duly obtained.</p><p><strong>Statistical analysis used: </strong>Percentage assessment was used for statistical analysis.</p><p><strong>Results: </strong>The cultures showed the presence of <i>Staphylococcus aureus</i> in 50% of bacterial isolates obtained from the involved eyes, followed by coagulase-negative <i>Staphylococcus</i> in 11.53% of isolates and <i>Enterococcus</i> also in 11.53% of isolates. It was observed that cefoxitin was the most sensitive antibiotic against Gram-positive organisms, followed by vancomycin and clindamycin, whereas maximum resistance was seen for penicillin and ofloxacin. For Gram-negative organisms, imipenem was found to be most sensitive, followed by gentamicin and co-amoxiclav, whereas maximum resistance was seen for ciprofloxacin.</p><p><strong>Conclusions: </strong>It was concluded that Gram-positive bacteria predominantly <i>S.</i> <i>aureus</i> was the most commonly isolated bacteria in cases of chronic dacryocystitis as compared to Gram-negative bacteria and cefoxitin was found to be the overall most effective antibiotic for Gram-positive bacteria.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"192-197"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manifestations of COVID-19 in the posterior eye segment - Up-to-date. COVID-19在眼球后段的表现--最新进展。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_212_22
Basheer Abdullah Marzoog

Since coronavirus disease infection-19 (COVID-19) entry to the cells is angiotensin enzyme receptor (ACEII) dependent, extrapulmonary manifestations have been suspected. Ocular manifestations reported in several studies to involve the anterior as well as posterior eye segments. However, the predominance of the anterior eye segment reduced the attention of the scientific community on the posterior eye segment. Our results showed that the incidence of changes in the posterior eye segment is 1/5 of the anterior eye segment. Posterior eye segment manifestations include acute macular neuroretinopathy and paracentral middle maculopathy, central retinal vein/artery occlusion, reactivation of previous uveitis, varicella zoster virus-related acute retinal necrosis in an immunocompromised patient, chorioretinitis, macular hemorrhage, paracentral acute middle maculopathy, retinal detachment, and vitritis with outer retinal abnormalities. The pathogenesis of posterior eye segment manifestations under COVID-19 includes viremia, autoimmune vasculitis, hyperimmune response, coagulopathy, and cytokine storm. A full ophthalmological examination is crucial for patients recovering from COVID-19. The paper provided up-to-date manifestations with potential underlying pathophysiological mechanisms of development, as well as pathogenetic therapy.

由于冠状病毒病感染-19(COVID-19)进入细胞依赖于血管紧张素酶受体(ACEII),因此怀疑会出现肺外表现。一些研究报告称,眼部表现涉及前眼球和后眼球。然而,由于前眼球表现占主导地位,减少了科学界对后眼球表现的关注。我们的研究结果表明,后眼节变化的发生率是前眼节的 1/5。后眼节表现包括急性黄斑神经视网膜病变和旁中心黄斑中间病变、视网膜中央静脉/动脉闭塞、既往葡萄膜炎再激活、免疫力低下患者水痘带状疱疹病毒相关急性视网膜坏死、脉络膜视网膜炎、黄斑出血、旁中心急性黄斑中间病变、视网膜脱离和玻璃体炎伴视网膜外层异常。COVID-19 后眼节表现的发病机制包括病毒血症、自身免疫性血管炎、高免疫反应、凝血病和细胞因子风暴。全面的眼科检查对 COVID-19 患者的康复至关重要。论文提供了最新的表现形式、潜在的潜在病理生理发展机制以及病理治疗方法。
{"title":"Manifestations of COVID-19 in the posterior eye segment - Up-to-date.","authors":"Basheer Abdullah Marzoog","doi":"10.4103/ojo.ojo_212_22","DOIUrl":"10.4103/ojo.ojo_212_22","url":null,"abstract":"<p><p>Since coronavirus disease infection-19 (COVID-19) entry to the cells is angiotensin enzyme receptor (ACEII) dependent, extrapulmonary manifestations have been suspected. Ocular manifestations reported in several studies to involve the anterior as well as posterior eye segments. However, the predominance of the anterior eye segment reduced the attention of the scientific community on the posterior eye segment. Our results showed that the incidence of changes in the posterior eye segment is 1/5 of the anterior eye segment. Posterior eye segment manifestations include acute macular neuroretinopathy and paracentral middle maculopathy, central retinal vein/artery occlusion, reactivation of previous uveitis, varicella zoster virus-related acute retinal necrosis in an immunocompromised patient, chorioretinitis, macular hemorrhage, paracentral acute middle maculopathy, retinal detachment, and vitritis with outer retinal abnormalities. The pathogenesis of posterior eye segment manifestations under COVID-19 includes viremia, autoimmune vasculitis, hyperimmune response, coagulopathy, and cytokine storm. A full ophthalmological examination is crucial for patients recovering from COVID-19. The paper provided up-to-date manifestations with potential underlying pathophysiological mechanisms of development, as well as pathogenetic therapy.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"166-172"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rare diagnosis of Von Hippel-Lindau disease in a 29-year-old patient. 一名 29 岁患者罕见地被诊断出患有 Von Hippel-Lindau 病。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_161_22
Tryfon Rotsos, Peggy Bouzika, Maria-Evanthia Sotirianakou, Chrysanthos Symeonidis, Ioannis Giachos, Evangelia Papakonstantinou, Theodoros Paraskevopoulos, Ilias Georgalas
{"title":"The rare diagnosis of Von Hippel-Lindau disease in a 29-year-old patient.","authors":"Tryfon Rotsos, Peggy Bouzika, Maria-Evanthia Sotirianakou, Chrysanthos Symeonidis, Ioannis Giachos, Evangelia Papakonstantinou, Theodoros Paraskevopoulos, Ilias Georgalas","doi":"10.4103/ojo.ojo_161_22","DOIUrl":"10.4103/ojo.ojo_161_22","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"287-290"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of large-scale use of vancomycin injection in infusion bottle during vitreoretinal procedures. 在玻璃体视网膜手术中大规模使用输液瓶中的万古霉素注射液的有效性和安全性。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_39_24
Subhendu Kumar Boral, Deepak Agarwal, Arnab Das, Debdulal Chakraborty, Santanu Mandal, Tushar Kanti Sinha

Purpose: The purpose of this study was to assess the safety and efficacy of large-scale use of vancomycin injection in an infusion bottle during vitreoretinal procedures.

Materials and methods: This was a retrospective evaluation of all vitreoretinal procedures done in the last 70 months, where intraoperatively vancomycin injection (0.2 mg/mL) was used in an infusion bottle prophylactically as standard care. Vitreoretinal procedures were categorized as major (duration >30 min), minor (duration <30 min), and silicone oil removal. Postoperatively, a detailed ocular examination was done to rule out hemorrhagic occlusive retinal vasculitis (HORV) or signs of postoperative bacterial endophthalmitis.

Results: Over the last 70 months, a total of 31,720 vitreoretinal procedures were performed, which included 24,371 major vitreoretinal procedures, 1401 minor vitreoretinal procedures, and 5948 silicone oil removal cases. None of these cases developed HORV or bacterial endophthalmitis.

Conclusion: Vancomycin (0.2 mg/mL) in infusion fluid during vitreoretinal procedures is safe and can be advocated as a prophylactic measure against postvitrectomy bacterial infections.

目的:本研究旨在评估在玻璃体视网膜手术中大规模使用输液瓶注射万古霉素的安全性和有效性:这是一项对过去 70 个月内完成的所有玻璃体视网膜手术的回顾性评估,在这些手术中,万古霉素注射液(0.2 mg/mL)作为标准护理在输液瓶中预防性使用。玻璃体视网膜手术分为大手术(持续时间超过 30 分钟)和小手术(持续时间超过 30 分钟):在过去的 70 个月中,共进行了 31720 例玻璃体视网膜手术,其中包括 24371 例大型玻璃体视网膜手术、1401 例小型玻璃体视网膜手术和 5948 例硅油去除手术。这些病例中没有一例出现 HORV 或细菌性眼内炎:结论:在玻璃体视网膜手术中将万古霉素(0.2 毫克/毫升)加入输液中是安全的,可作为预防玻璃体切除术后细菌感染的措施。
{"title":"Efficacy and safety of large-scale use of vancomycin injection in infusion bottle during vitreoretinal procedures.","authors":"Subhendu Kumar Boral, Deepak Agarwal, Arnab Das, Debdulal Chakraborty, Santanu Mandal, Tushar Kanti Sinha","doi":"10.4103/ojo.ojo_39_24","DOIUrl":"10.4103/ojo.ojo_39_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess the safety and efficacy of large-scale use of vancomycin injection in an infusion bottle during vitreoretinal procedures.</p><p><strong>Materials and methods: </strong>This was a retrospective evaluation of all vitreoretinal procedures done in the last 70 months, where intraoperatively vancomycin injection (0.2 mg/mL) was used in an infusion bottle prophylactically as standard care. Vitreoretinal procedures were categorized as major (duration >30 min), minor (duration <30 min), and silicone oil removal. Postoperatively, a detailed ocular examination was done to rule out hemorrhagic occlusive retinal vasculitis (HORV) or signs of postoperative bacterial endophthalmitis.</p><p><strong>Results: </strong>Over the last 70 months, a total of 31,720 vitreoretinal procedures were performed, which included 24,371 major vitreoretinal procedures, 1401 minor vitreoretinal procedures, and 5948 silicone oil removal cases. None of these cases developed HORV or bacterial endophthalmitis.</p><p><strong>Conclusion: </strong>Vancomycin (0.2 mg/mL) in infusion fluid during vitreoretinal procedures is safe and can be advocated as a prophylactic measure against postvitrectomy bacterial infections.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"234-236"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital malignant peripheral nerve sheath tumor: A case report and review. 眼眶恶性周围神经鞘瘤:病例报告和综述。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_299_23
Syed Wajahat Ali Rizvi, Syed Ali Raza Rizvi, Shagufta Qadri, Saifullah Khalid, Mohammed Azfar Siddiqui, Adeeb Alam Khan, Afeefa Akhter

Malignant peripheral nerve sheath tumor of the orbit is an exceedingly rare entity. These tumors exhibit locally aggressive behavior, recurrences, distant metastasis, and poor response to existing treatment protocols. Orbital nerve sheath tumors are often associated with neurofibromatosis 1, and malignant transformation of neurofibroma into malignant nerve sheath tumor has also been seen. The recommended treatment for localized disease is radical or wide surgical excision to achieve negative margins followed by chemoradiation. For extensive disease, chemotherapy and radiotherapy can be utilized to stabilize the disease. Due to poor response and outcomes with current regimens, the focus has been shifted to approaches utilizing molecular targets and immunological agents. Despite all the advancements, the outcomes still remain discouraging for moderate- to high-grade lesions and thus necessitate studies to design promising treatment modalities.

眼眶恶性周围神经鞘瘤极为罕见。这些肿瘤具有局部侵袭性、复发、远处转移以及对现有治疗方案反应差等特点。眼眶神经鞘瘤通常与神经纤维瘤病 1 有关,神经纤维瘤恶性转化为恶性神经鞘瘤的情况也时有发生。对于局部疾病,推荐的治疗方法是根治性或广泛性手术切除,以达到阴性边缘,然后进行化疗。对于广泛性疾病,可采用化疗和放疗来稳定病情。由于目前的治疗方案反应不佳、疗效不佳,治疗重点已转移到利用分子靶点和免疫制剂的方法上。尽管取得了这些进展,但中度至高度病变的治疗效果仍然令人沮丧,因此有必要进行研究,以设计出有前途的治疗模式。
{"title":"Orbital malignant peripheral nerve sheath tumor: A case report and review.","authors":"Syed Wajahat Ali Rizvi, Syed Ali Raza Rizvi, Shagufta Qadri, Saifullah Khalid, Mohammed Azfar Siddiqui, Adeeb Alam Khan, Afeefa Akhter","doi":"10.4103/ojo.ojo_299_23","DOIUrl":"10.4103/ojo.ojo_299_23","url":null,"abstract":"<p><p>Malignant peripheral nerve sheath tumor of the orbit is an exceedingly rare entity. These tumors exhibit locally aggressive behavior, recurrences, distant metastasis, and poor response to existing treatment protocols. Orbital nerve sheath tumors are often associated with neurofibromatosis 1, and malignant transformation of neurofibroma into malignant nerve sheath tumor has also been seen. The recommended treatment for localized disease is radical or wide surgical excision to achieve negative margins followed by chemoradiation. For extensive disease, chemotherapy and radiotherapy can be utilized to stabilize the disease. Due to poor response and outcomes with current regimens, the focus has been shifted to approaches utilizing molecular targets and immunological agents. Despite all the advancements, the outcomes still remain discouraging for moderate- to high-grade lesions and thus necessitate studies to design promising treatment modalities.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"254-260"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of deep anterior lamellar keratoplasty in eyes with healed hydrops - A retrospective interventional analysis. 对水肿痊愈的眼睛进行深前板层角膜移植术的结果 - 一项回顾性介入分析。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_242_22
Shreesha Kumar Kodavoor, B Soundarya, Ramamurthy Dandapani

Aim: The aim of the study was to analyze the techniques and outcomes of deep anterior lamellar keratoplasty (DALK) done in eyes with healed hydrops.

Methods: Thirty-one eyes with paracentral scars following acute hydrops underwent DALK and were included in the study. Manual layer-by-layer dissection with stromal air injection was done in all cases, keeping dissection of the site of preexisting perforation to the end.

Results: Out of the 31 eyes, in 28 eyes, DALK could be completed, and in 3 eyes, procedure had to be converted to penetrating keratoplasty. Visual outcomes in all cases were good, with 26 out of 28 eyes (92.8%) achieving a best-corrected visual acuity (BCVA) of 6/12 or better. Preoperative mean BCVA of LogMAR 1.19 ± 0.27 improved to a postoperative mean BCVA of LogMAR 0.23 ± 0.08 (P < 0.00001). Postoperative mean refractive astigmatism at the last follow-up was -2.69 ± 0.82 D with postoperative a spherical equivalent of -2.31 ± 0.7 D. Complications included double anterior chamber in one eye and secondary angle closure in two eyes. Stromal rejection in one eye was managed with steroids and one eye with suture infiltrate needed selective suture removal.

Conclusion: Layer-by-layer dissection with limited air injection into the stroma has shown good visual outcomes in patients undergoing DALK following healed hydrops, and DALK can very well be the primary treatment option even in such cases with a paracentral posthydrops scar.

目的:本研究旨在分析在水肿痊愈的眼睛中进行深前板层角膜移植术(DALK)的技术和结果:31只急性水肿后伴有中央旁疤痕的眼睛接受了DALK手术,并被纳入研究范围。所有病例均采用人工逐层剥离并注入基质空气的方法,最后对原有穿孔部位进行剥离:结果:在31只眼睛中,28只眼睛的DALK手术得以完成,3只眼睛的手术不得不转为穿透性角膜成形术。所有病例的视觉效果都很好,28 只眼睛中有 26 只(92.8%)的最佳矫正视力(BCVA)达到或超过 6/12。术前平均 BCVA 为 LogMAR 1.19 ± 0.27,术后平均 BCVA 为 LogMAR 0.23 ± 0.08(P < 0.00001)。术后最后一次随访时的平均屈光散光度数为-2.69 ± 0.82 D,术后球面等效度数为-2.31 ± 0.7 D。并发症包括一只眼睛的前房重影和两只眼睛的继发性角膜闭合。一只眼的基质排斥用类固醇治疗,一只眼的缝线浸润需要选择性切除缝线:逐层剥离并在基质中注入有限的空气对水肿愈合后接受 DALK 的患者有良好的视觉效果。
{"title":"Outcomes of deep anterior lamellar keratoplasty in eyes with healed hydrops - A retrospective interventional analysis.","authors":"Shreesha Kumar Kodavoor, B Soundarya, Ramamurthy Dandapani","doi":"10.4103/ojo.ojo_242_22","DOIUrl":"10.4103/ojo.ojo_242_22","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the study was to analyze the techniques and outcomes of deep anterior lamellar keratoplasty (DALK) done in eyes with healed hydrops.</p><p><strong>Methods: </strong>Thirty-one eyes with paracentral scars following acute hydrops underwent DALK and were included in the study. Manual layer-by-layer dissection with stromal air injection was done in all cases, keeping dissection of the site of preexisting perforation to the end.</p><p><strong>Results: </strong>Out of the 31 eyes, in 28 eyes, DALK could be completed, and in 3 eyes, procedure had to be converted to penetrating keratoplasty. Visual outcomes in all cases were good, with 26 out of 28 eyes (92.8%) achieving a best-corrected visual acuity (BCVA) of 6/12 or better. Preoperative mean BCVA of LogMAR 1.19 ± 0.27 improved to a postoperative mean BCVA of LogMAR 0.23 ± 0.08 (<i>P</i> < 0.00001). Postoperative mean refractive astigmatism at the last follow-up was -2.69 ± 0.82 D with postoperative a spherical equivalent of -2.31 ± 0.7 D. Complications included double anterior chamber in one eye and secondary angle closure in two eyes. Stromal rejection in one eye was managed with steroids and one eye with suture infiltrate needed selective suture removal.</p><p><strong>Conclusion: </strong>Layer-by-layer dissection with limited air injection into the stroma has shown good visual outcomes in patients undergoing DALK following healed hydrops, and DALK can very well be the primary treatment option even in such cases with a paracentral posthydrops scar.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"210-213"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous appearance and resolution of vitreous hemorrhage after bevacizumab injection in retinopathy of prematurity. 早产儿视网膜病变注射贝伐单抗后玻璃体出血的自发出现和消退。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_58_23
Abhishek Das, Prema Subramaniam, Parag K Shah, Venkatapathy Narendran
{"title":"Spontaneous appearance and resolution of vitreous hemorrhage after bevacizumab injection in retinopathy of prematurity.","authors":"Abhishek Das, Prema Subramaniam, Parag K Shah, Venkatapathy Narendran","doi":"10.4103/ojo.ojo_58_23","DOIUrl":"10.4103/ojo.ojo_58_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"293-295"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Boergen modification of Harada-ito surgery with and without vertical muscle surgery for acquired unilateral superior oblique muscle palsy. 对获得性单侧上斜肌麻痹进行 Boergen 改良 Harada-ito 手术,同时进行和不进行垂直肌肉手术。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_183_23
Hajar Farvardin, Hadi Farvardin, Majid Farvardin

Purpose: The purpose is to report the results of the Boergen modification of the Harada-Ito procedure with and without simultaneous vertical muscle surgery in patients with acquired unilateral superior oblique muscle palsy.

Patients and methods: Files of patients with acquired unilateral superior oblique muscle palsy who were treated with Boergen modification of the Harada-Ito procedure were studied retrospectively. For each patient, age at the time of surgery, the presence of diplopia, compensatory head posture, and ocular deviation before and after surgery were retrieved. Results were evaluated 6 months after surgery.

Results: A total of 12 patients with a mean age of 32 years at the time of surgery (range 15-45 years) were included. The underlying etiology was head trauma in eleven patients. The modified Harada-Ito procedure alone was done for three cases (Group 1), and a simultaneous combination of this procedure and vertical muscle surgery was performed in nine patients (Group 2). The average intorsional effect in the primary position was 9.2° (8° in Group 1 and 9.6° in Group 2). The average correction of hypertropia in the primary position was 8.2 prism diopters (PD) (1 PD in Group 1 and 10.6 PD in Group 2). Diplopia in the primary position and downgaze were resolved in eleven patients and ten patients, respectively. Four patients had a compensatory head tilt at their last follow-up.

Conclusions: Boergen modification of the Harada-Ito procedure, alone and combined with vertical muscle surgery, successfully corrected primary position diplopia in the majority of the patients.

目的:旨在报告在后天性单侧上斜肌麻痹患者中采用 Boergen 改良 Harada-Ito 手术并同时进行或不进行垂直肌肉手术的结果:回顾性研究了使用 Boergen 改良 Harada-Ito 手术治疗后天性单侧上斜肌麻痹患者的病历。检索了每位患者手术时的年龄、手术前后是否复视、代偿性头部姿势和眼球偏斜情况。术后 6 个月对结果进行评估:结果:共纳入 12 名患者,手术时平均年龄为 32 岁(15-45 岁不等)。11例患者的病因是头部外伤。3例患者(第1组)只接受了改良原田-伊藤手术,9例患者(第2组)同时接受了该手术和垂直肌肉手术。原位的平均内收效果为 9.2°(第一组为 8°,第二组为 9.6°)。原位高视平的平均矫正度数为 8.2 个棱镜屈光度 (PD)(第一组为 1 个 PD,第二组为 10.6 个 PD)。分别有 11 名患者和 10 名患者的主视位复视和下视得到了矫正。四名患者在最后一次随访时出现了代偿性头部倾斜:Boergen改良原田-伊藤手术单独或与垂直肌肉手术相结合,成功矫正了大多数患者的原位复视。
{"title":"Boergen modification of Harada-ito surgery with and without vertical muscle surgery for acquired unilateral superior oblique muscle palsy.","authors":"Hajar Farvardin, Hadi Farvardin, Majid Farvardin","doi":"10.4103/ojo.ojo_183_23","DOIUrl":"10.4103/ojo.ojo_183_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose is to report the results of the Boergen modification of the Harada-Ito procedure with and without simultaneous vertical muscle surgery in patients with acquired unilateral superior oblique muscle palsy.</p><p><strong>Patients and methods: </strong>Files of patients with acquired unilateral superior oblique muscle palsy who were treated with Boergen modification of the Harada-Ito procedure were studied retrospectively. For each patient, age at the time of surgery, the presence of diplopia, compensatory head posture, and ocular deviation before and after surgery were retrieved. Results were evaluated 6 months after surgery.</p><p><strong>Results: </strong>A total of 12 patients with a mean age of 32 years at the time of surgery (range 15-45 years) were included. The underlying etiology was head trauma in eleven patients. The modified Harada-Ito procedure alone was done for three cases (Group 1), and a simultaneous combination of this procedure and vertical muscle surgery was performed in nine patients (Group 2). The average intorsional effect in the primary position was 9.2° (8° in Group 1 and 9.6° in Group 2). The average correction of hypertropia in the primary position was 8.2 prism diopters (PD) (1 PD in Group 1 and 10.6 PD in Group 2). Diplopia in the primary position and downgaze were resolved in eleven patients and ten patients, respectively. Four patients had a compensatory head tilt at their last follow-up.</p><p><strong>Conclusions: </strong>Boergen modification of the Harada-Ito procedure, alone and combined with vertical muscle surgery, successfully corrected primary position diplopia in the majority of the patients.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"214-218"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conjunctival nodule as a primary manifestation of disseminated histoplasmosis. 结膜结节是播散性组织胞浆菌病的主要表现。
Q3 Medicine Pub Date : 2024-06-27 eCollection Date: 2024-05-01 DOI: 10.4103/ojo.ojo_158_23
Chhavi Gupta Narula, Arpan Gandhi, Sima Das

Histoplasmosis is a granulomatous infection caused by dimorphic fungus-Histoplasma capsulatum. Ocular involvement is mainly in the form of retinal or choroidal involvement as presumed ocular histoplasmosis mostly in immunocompromised patients. Conjunctival, scleral, and adnexal involvement is rarely reported. We report a case of disseminated histoplasmosis with conjunctival lesion as the initial clinical manifestation clinching the diagnosis.

组织胞浆菌病是由二形真菌--荚膜组织胞浆菌引起的肉芽肿性感染。眼部受累主要表现为视网膜或脉络膜受累,因为推测眼部组织胞浆菌病主要发生在免疫力低下的患者身上。结膜、巩膜和附件受累的报道很少。我们报告了一例以结膜病变为最初临床表现的播散性组织胞浆菌病病例,该病例最终确诊。
{"title":"Conjunctival nodule as a primary manifestation of disseminated histoplasmosis.","authors":"Chhavi Gupta Narula, Arpan Gandhi, Sima Das","doi":"10.4103/ojo.ojo_158_23","DOIUrl":"10.4103/ojo.ojo_158_23","url":null,"abstract":"<p><p>Histoplasmosis is a granulomatous infection caused by dimorphic fungus-<i>Histoplasma capsulatum</i>. Ocular involvement is mainly in the form of retinal or choroidal involvement as presumed ocular histoplasmosis mostly in immunocompromised patients. Conjunctival, scleral, and adnexal involvement is rarely reported. We report a case of disseminated histoplasmosis with conjunctival lesion as the initial clinical manifestation clinching the diagnosis.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"275-277"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oman Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1